ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2774

Distinct Role Of Plasmacytoid Dendritic Cells and Mast Cells In The Pathogenesis Of Sjӧgren’s Syndrome

Jidong Zhao1, Kunihiro Yamaoka1, Satoshi Kubo1, Shingo Nakayamada2 and Yoshiya Tanaka1, 1The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan, 2First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Dendritic cells, histopathologic and mast cells, Sjogren's syndrome

  • Tweet
  • Email
  • Print
Session Information

Title: Sjögren's Syndrome: Basic Science

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Sjögren’s Syndrome (SS) is characterized by the destruction of the lacrimal and salivary grands due to autoreactive lymphocyte infiltration in the early phase and subsequent intralobular fibrosis and acinar atrophy at late phase of the disease. Involvement of plasmacytoid dendritic cells (pDCs) and mast cells (MCs) has been suggested, although their detailed role in pathology is poorly understood. The aim of this study was to investigate the role pDCs and MCs in the disease course of SS.

Methods:

 Lip biopsy specimen from 178 SS patients and 7 Sicca syndrome (Sicca) patients were analyzed. NanoZoomer Digital Pathology (NDP), a system to convert a histology slide into high-resolution digital slides and enables sequential pathological analysis of multiple sections and measurement of accurate specimen area was utilized for analysis. Density of pDCs and MCs (/mm2) was measured with NDP and histological scoring was performed on lymphocytes infiltration, acinar atrophy and intralobular fibrosis. pDC, CXCL13 and CD68 were detected by immunohistochemistry and MCs were detected by toluidine blue staining. Histological stage was based on ‘Greenspan grade’.

Results: Significant lymphocytes infiltration, acinar atrophy and intralobular fibrosis were observed in SS compared to Sicca patients with salivary gland destruction. Both, pDCs and MCs were significantly increased in SS compared to Sicca (12.6±10.2 vs 3.4±3.7, 43.7±21.8 vs 21.5±6.9). Positive correlation between density of pDCs with lymphocytes infiltration score (p��0.02) and density of MCs with intralobular fibrosis score (p��0.03) was observed in primary SS but not in secondary SS. Moreover, in the primary SS, density of CXCL13 positive infiltrating cells positively correlated with the degree of lymphocyte infiltration score and density of pDCs (p<0.001); by double immunostaining of anti-CXCL13 and anti-CD68, we found that most of CXCL13 positive infiltrating cells are from Macrophage(57.8±22.1%) and the localization of PDC and CXCL13 positive infiltrating cells are almost same around duct. On the other hand, no correlation was observed with secondary SS patients.

Conclusion: Our data suggests the specific role of pDCs in lymphocyte infiltration in primary SS. Correlation of CXCL13 expression, a chemoattractant for lymphocyte recruitement, with lymphocyte infiltration and density of pDCs further suggests the important role of pDCs. CXCL13 is induced by type1 IFN, whereas pDCs are the major source of type 1 IFN. Therefore, it likely that type 1 IFN produced by pDCs in the early stage of the disease induces CXCL13 production of infiltrating cells, especially Macrophage, contributing to lymphocyte infiltration constructing germinal center. In addition, MCs seems to be involved in intralobular fibrosis which occurs in the mid to late stage of SS.


Disclosure:

J. Zhao,
None;

K. Yamaoka,
None;

S. Kubo,
None;

S. Nakayamada,
None;

Y. Tanaka,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/distinct-role-of-plasmacytoid-dendritic-cells-and-mast-cells-in-the-pathogenesis-of-sj%d3%a7grens-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology